Connection

W. Garvey to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications W. Garvey has written about Drug Evaluation, Preclinical.
W. Garvey
Connection Strength
0.037
Drug Evaluation, Preclinical
  1. The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis. J Dermatol Sci. 2018 Jun; 90(3):343-356.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.